Next earnings date: 27 Aug 2025
Cell MedX Corp. – OTC:CMXC
Cell MedX Corp. stock price today
Cell MedX Corp. stock price monthly change
Cell MedX Corp. stock price yearly change
Cell MedX Corp. key metrics
Market Cap | 126.32M |
Enterprise value | 2.35M |
P/E | -1.45 |
EV/Sales | 1006.49 |
EV/EBITDA | -2.68 |
Price/Sales | 779.81 |
Price/Book | -0.99 |
PEG ratio | 744.73 |
EPS | N/A |
Revenue | N/A |
EBITDA | -382.28K |
Income | -240.13K |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -37440.51% |
Oper. margin | -27948.12% |
Gross margin | 71.24% |
EBIT margin | -27948.12% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCell MedX Corp. stock price history
Cell MedX Corp. stock forecast
Cell MedX Corp. financial statements
| May 2022 | 2.77K | -162.56K | -5858.05% |
|---|---|---|---|
| Feb 2023 | 222 | -118.16K | -53225.68% |
| May 2023 | 74 | -79.38K | -107274.32% |
| Feb 2024 | 0 | 119.97K |
| Nov 2022 | 24022 | 2.22M | 9255.5% |
|---|---|---|---|
| Feb 2023 | 13896 | 2.31M | 16685.25% |
| May 2023 | 103270 | 2.48M | 2409.94% |
| Feb 2024 | 81918 | 791.86K | 966.65% |
| May 2022 | -94.57K | 0 | 88.09K |
|---|---|---|---|
| Feb 2023 | -103.36K | 0 | 92.61K |
| May 2023 | -25.62K | 0 | 116.37K |
| Feb 2024 | -37.94K | 0 | 95K |
Cell MedX Corp. other data
| Period | Buy | Sel |
|---|---|---|
| Dec 2023 | 29372285 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | JEFFS RICHARD 10 percent owner | Common Shares | 14,372,285 | $0.01 | $100,606 | ||
Purchase | JEFFS DAVID director, 10 percent owner, off.. | Common Shares | 7,500,000 | $0.01 | $52,500 | ||
Purchase | JEFFS DAVID director, 10 percent owner, off.. | Common Shares | 7,500,000 | $0.01 | $52,500 | ||
Sale | HARGREAVES BRADLEY S director, 10 perc.. | Common stock | 10,000 | $0.15 | $1,500 | ||
Sale | HARGREAVES BRADLEY S director, 10 perc.. | Common stock | 300 | $0.18 | $54 | ||
Sale | HARGREAVES BRADLEY S director, 10 perc.. | Common stock | 300 | $0.18 | $54 | ||
Sale | HARGREAVES BRADLEY S director, 10 perc.. | Common stock | 7,000 | $0.15 | $1,050 | ||
Sale | HARGREAVES BRADLEY S director, 10 perc.. | Common stock | 7,500 | $0.15 | $1,118 | ||
Sale | HARGREAVES BRADLEY S director, 10 perc.. | Common stock | 5,000 | $0.19 | $925 | ||
Sale | HARGREAVES BRADLEY S director, 10 perc.. | Common stock | 5,000 | $18.2 | $91,000 |
| Insider | Compensation |
|---|---|
Mr. Joao da Costa (1964) Chief Operating Officer & Director | $157,920 |
| Mr. Bradley S. Hargreaves (1959) Vice President of Technology & Operations and Director | $46,020 |
Ms. Yanika Silina C.M.A., CPA (1978) Chief Financial Officer, Treasurer, Corporation Sec. & Director | $28,500 |
Mr. Frank Edward McEnulty (1956) Chief Executive Officer & Director | $12,000 |
-
What's the price of Cell MedX Corp. stock today?
One share of Cell MedX Corp. stock can currently be purchased for approximately $0.03.
-
When is Cell MedX Corp.'s next earnings date?
Cell MedX Corp. is estimated to report earnings on Wednesday, 27 Aug 2025.
-
Does Cell MedX Corp. pay dividends?
No, Cell MedX Corp. does not pay dividends.
-
How much money does Cell MedX Corp. make?
Cell MedX Corp. has a market capitalization of 126.32M.
-
What is Cell MedX Corp.'s stock symbol?
Cell MedX Corp. is traded on the OTC under the ticker symbol "CMXC".
-
What is Cell MedX Corp.'s primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Cell MedX Corp.?
Shares of Cell MedX Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Cell MedX Corp.'s key executives?
Cell MedX Corp.'s management team includes the following people:
- Mr. Joao da Costa Chief Operating Officer & Director(age: 61, pay: $157,920)
- Mr. Bradley S. Hargreaves Vice President of Technology & Operations and Director(age: 66, pay: $46,020)
- Ms. Yanika Silina C.M.A., CPA Chief Financial Officer, Treasurer, Corporation Sec. & Director(age: 47, pay: $28,500)
- Mr. Frank Edward McEnulty Chief Executive Officer & Director(age: 69, pay: $12,000)
-
When Cell MedX Corp. went public?
Cell MedX Corp. is publicly traded company for more then 12 years since IPO on 29 Aug 2013.
-
What is Cell MedX Corp.'s official website?
The official website for Cell MedX Corp. is cellmedx.com.
-
Where are Cell MedX Corp.'s headquarters?
Cell MedX Corp. is headquartered at 123 West Nye Ln, Carson City, NV.
-
How can i contact Cell MedX Corp.?
Cell MedX Corp.'s mailing address is 123 West Nye Ln, Carson City, NV and company can be reached via phone at +84 42382692.
Cell MedX Corp. company profile:
Cell MedX Corp.
cellmedx.comOTC
0
Medical - Devices
Healthcare
Cell MedX Corp., a biotech company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is based in Carson City, Nevada.
Carson City, NV 89706
CIK: 0001493712
ISIN: US15115X1072
CUSIP: 15115X107
